Hemolytic Plaque Technique
"Hemolytic Plaque Technique" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method to identify and enumerate cells that are synthesizing ANTIBODIES against ANTIGENS or HAPTENS conjugated to sheep RED BLOOD CELLS. The sheep red blood cells surrounding cells secreting antibody are lysed by added COMPLEMENT producing a clear zone of HEMOLYSIS. (From Illustrated Dictionary of Immunology, 3rd ed)
| Descriptor ID |
D006462
|
| MeSH Number(s) |
E01.370.225.812.375 E05.200.812.375 E05.478.594.375
|
| Concept/Terms |
Hemolytic Plaque Technique- Hemolytic Plaque Technique
- Hemolytic Plaque Techniques
- Plaque Technique, Hemolytic
- Plaque Techniques, Hemolytic
- Technique, Hemolytic Plaque
- Techniques, Hemolytic Plaque
- Jerne's Plaque Technique
- Jerne Plaque Technique
- Jernes Plaque Technique
- Plaque Technique, Jerne's
- Technique, Jerne's Plaque
- Hemolytic Plaque Technic
- Hemolytic Plaque Technics
- Plaque Technic, Hemolytic
- Plaque Technics, Hemolytic
- Technic, Hemolytic Plaque
- Technics, Hemolytic Plaque
- Jerne's Plaque Technic
- Jerne Plaque Technic
- Jernes Plaque Technic
- Plaque Technic, Jerne's
- Technic, Jerne's Plaque
|
Below are MeSH descriptors whose meaning is more general than "Hemolytic Plaque Technique".
Below are MeSH descriptors whose meaning is more specific than "Hemolytic Plaque Technique".
This graph shows the total number of publications written about "Hemolytic Plaque Technique" by people in this website by year, and whether "Hemolytic Plaque Technique" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Hemolytic Plaque Technique" by people in Profiles.
-
Ellison RT, Curd JG, Kohler PF, Reller LB, Judson FN. Underlying complement deficiency in patients with disseminated gonococcal infection. Sex Transm Dis. 1987 Oct-Dec; 14(4):201-4.
-
Murray PD, Swain SL, Kagnoff MP. Regulation of the IgM and IgA anti-dextran B1355S response: synergy between IFN-gamma, BCGF II, and IL 2. J Immunol. 1985 Dec; 135(6):4015-20.
-
Sidman CL, Shultz LD, Evans R. A serum-derived molecule from autoimmune viable motheaten mice potentiates the action of a B cell maturation factor. J Immunol. 1985 Aug; 135(2):870-2.
-
Swain SL. Role of BCGFII in the differentiation to antibody secretion normal and tumor B cells. J Immunol. 1985 Jun; 134(6):3934-43.
-
Ely JM, Greiner DL, Lubaroff DM, Fitch FW. Characterization of monoclonal antibodies that define rat T cell alloantigens. J Immunol. 1983 Jun; 130(6):2798-803.
-
Campos-Neto A, Bunn-Moreno MM. Polyclonal B cell activation in hamsters infected with parasites of the genus Leishmania. Infect Immun. 1982 Dec; 38(3):871-6.
-
Petersen J, Kieffer M, Lilic D, Rathlev N, Andersen V. Influence of autologous monocytes on the pokeweed mitogen-induced generation of immunoglobulin-secreting cells in man. Scand J Haematol. 1982 Oct; 29(4):273-82.
-
Sidman CL, Shultz LD, Unanue ER. The mouse mutant "motheaten". I. Development of lymphocyte populations. J Immunol. 1978 Dec; 121(6):2392-8.
-
Sidman CL, Shultz LD, Unanue ER. The mouse mutant "motheaten." II. Functional studies of the immune system. J Immunol. 1978 Dec; 121(6):2399-404.
-
Swain SL, Dutton RW. Negative allogeneic effects in vitro. II. Mapping of histocompatibility differences leading to allosuppression. J Immunol. 1977 Sep; 119(3):1179-86.